Related Experiment Videos

Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+

E Wu1, T Shinka, P Caldera-Munoz

  • 1Division of Toxicology, University of California School of Pharmacy, San Francisco 94143-0446.

Insights

The study investigated the metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and MPDP+ in mouse brain and liver. MPTP is converted to MPP+ in the brain, while liver metabolism yields different products, including a novel lactam metabolite.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Toxicology

Background:

  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that selectively damages dopaminergic neurons in the nigrostriatal pathway.
  • The metabolic activation of MPTP to its toxic species is crucial for its neurotoxicity, involving oxidation to MPDP+ and MPP+.
  • Understanding the differential metabolism of MPTP and its metabolites in various tissues is essential for comprehending its toxicological profile.

Purpose of the Study:

  • To elucidate the metabolic pathways of MPTP and MPDP+ in mouse brain and liver subcellular fractions.
  • To identify and characterize the metabolites formed from MPTP and MPDP+ in these tissues.
  • To investigate the enzymes and cellular components involved in MPTP metabolism.

Main Methods:

  • Incubation of MPTP and MPDP+ with mouse brain and liver tissue fractions.
  • Analysis of metabolites using mass spectrometry (MS) and diode array UV spectroscopy.
  • Enzyme inhibition studies using menadione.
  • Structural characterization of metabolites using high-resolution 1H NMR and EI mass spectrometry.

Main Results:

  • In mouse brain, MPTP is metabolized to MPDP+ by MAO B, and further oxidized to MPP+ by membrane-associated components.
  • Mouse liver microsomes convert MPTP to desmethyl and N-oxide metabolites, and at high concentrations, to MPDP+ via NADPH-dependent enzymes.
  • MPDP+ is rapidly converted to a lactam metabolite, identified as 1-methyl-4-phenyl-5,6-dihydro-2-pyridone, in liver cytosols, a reaction inhibited by menadione, suggesting aldehyde oxidase involvement.

Conclusions:

  • MPTP metabolism differs significantly between mouse brain and liver.
  • The brain primarily converts MPTP to the toxic MPP+ species.
  • Liver metabolism of MPTP and MPDP+ leads to detoxification via novel pathways, including the formation of a lactam metabolite.

Related Concept Videos